- “Pioglitazone Tablets” already exists in your wishlist
In Stock
Nilotinib Capsules
Nilotinib Capsules 200mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • Updated 16 October 2026
Important: This is an educational guide, not a prescription or a substitute for advice from your cancer specialist.
Product Introduction
Nilocap 200 mg Capsule contains nilotinib 200 mg and is marketed by MSN Laboratories. Nilotinib is a targeted anticancer medicine used for certain patients with Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML).
This is a prescription-only medicine requiring specialist supervision. The dose and duration depend on diagnosis, treatment history, response, test results and tolerability. Do not determine the dose from capsule strength alone.
1. Uses
Used to treat selected patients with Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML), a type of blood cancer. Depending on the approved label and specialist judgement, it may be prescribed for newly diagnosed patients or those who have not responded to, or cannot tolerate, certain other treatments.
Treatment must be prescribed and monitored by an oncology or haematology specialist.
2. Benefits
Nilotinib blocks abnormal tyrosine kinase signalling, including BCR-ABL, which helps drive the growth of certain leukaemia cells.
For patients whose disease is sensitive to nilotinib, it can reduce abnormal cell growth and help control the disease. Response varies and requires regular monitoring.
3. Side Effects
Common side effects may include headache, nausea, abdominal pain, diarrhoea, constipation, rash, itching, fatigue, muscle or joint pain, fever, hair loss and changes in blood-cell counts or liver/pancreatic enzyme tests.
Serious risks include low blood-cell counts, liver problems, pancreatitis, changes in blood sugar or cholesterol, and QT interval prolongation (a potentially dangerous heart-rhythm problem). Sudden deaths have been reported in patients receiving nilotinib.
Seek urgent medical help for fainting, a fast or irregular heartbeat, chest pain, severe abdominal pain, unusual bleeding, fever with signs of infection, yellowing of the skin/eyes or a severe allergic reaction.
4. Safety Advice
Take only as prescribed. Do not change the dose, stop treatment or restart it without your specialist’s advice.
Your care team may arrange regular blood counts, liver tests, blood sugar and lipid tests, electrolyte checks (especially potassium and magnesium), and ECGs to monitor heart rhythm.
Tell your doctor about heart disease, an irregular heartbeat, long QT syndrome, liver or kidney problems, pancreatitis, diabetes, or any medicines and supplements you take.
Pregnancy: nilotinib may harm an unborn baby. Tell your specialist if you are pregnant, planning pregnancy or could become pregnant. Discuss reliable contraception during treatment and for the period advised after stopping.
Breastfeeding is not recommended during treatment. Ask your specialist for individual advice.
Avoid driving if you feel dizzy, faint or have vision changes. Ask your doctor about alcohol.
Store below 30°C and keep out of reach of children. Follow the product pack for any additional storage instructions.
5. How It Works
Nilotinib is a tyrosine kinase inhibitor. It blocks abnormal BCR-ABL signalling in certain leukaemia cells, slowing their growth and survival.
6. How to Use
Follow the exact dose and schedule prescribed by your specialist. The 200 mg capsule strength does not tell you how many capsules to take.
Take on an empty stomach: avoid food for at least 2 hours before each dose and for 1 hour after each dose. Food can increase drug absorption and the risk of side effects.
Swallow the capsule whole with water. Do not crush, chew or open it unless your specialist or pharmacist gives specific instructions.
Avoid grapefruit and grapefruit juice. Check with your doctor or pharmacist before using antacids, acid-reducing medicines, vitamins, minerals or herbal products.
If you miss a dose, do not take an extra dose to make up for it. Follow the package leaflet or ask your care team what to do.
Do not stop taking nilotinib unless your specialist tells you to.
7. Quick Tips
Keep all scheduled blood tests, ECGs and follow-up appointments.
Maintain a current list of prescription medicines, over-the-counter products, vitamins and herbal supplements and share it with your oncology team.
Report fainting, palpitations, chest pain, severe abdominal pain, fever, unusual bruising/bleeding or signs of liver problems promptly.
Keep the required food-free interval before and after each dose, and take the medicine consistently.
Use reliable contraception as advised by your specialist and do not breastfeed during treatment.
8. Drug Interactions
Nilotinib can interact with strong CYP3A4 inhibitors or inducers, medicines that prolong the QT interval, and medicines that reduce stomach acid. Examples include certain antifungals, antibiotics, seizure medicines, rifampicin, St John’s wort, antiarrhythmics and some antidepressants.
Do not start or stop any prescription medicine, antacid, supplement or herbal product without checking with your doctor or pharmacist. Some combinations can cause serious heart-rhythm problems or alter nilotinib levels. This is not a complete interaction list.
Medical Disclaimer
This document is for general educational purposes only and is not a substitute for medical advice, diagnosis or treatment. Nilotinib is a specialist-prescribed anticancer medicine. Do not use this guide to choose a dose or make treatment decisions. Always follow the current package leaflet and the instructions of your oncologist or pharmacist. In an emergency, seek urgent medical care.
| Product Name | Nilotinib Capsules |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 200mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
